244 related articles for article (PubMed ID: 20399254)
21. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice.
Puoliväli J; Wang J; Heikkinen T; Heikkilä M; Tapiola T; van Groen T; Tanila H
Neurobiol Dis; 2002 Apr; 9(3):339-47. PubMed ID: 11950278
[TBL] [Abstract][Full Text] [Related]
22. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
[TBL] [Abstract][Full Text] [Related]
23. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
24. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
[TBL] [Abstract][Full Text] [Related]
25. Presenilin 1-related alterations in DNA integrity in a transgenic mouse model of Alzheimer's disease.
Michelsen KA; Korr H; Steinbusch HW; Schmitz C
Brain Res; 2010 Feb; 1316():139-44. PubMed ID: 20034479
[TBL] [Abstract][Full Text] [Related]
26. Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.
Shilling D; Müller M; Takano H; Mak DO; Abel T; Coulter DA; Foskett JK
J Neurosci; 2014 May; 34(20):6910-23. PubMed ID: 24828645
[TBL] [Abstract][Full Text] [Related]
27. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
28. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
Chen Q; Nakajima A; Choi SH; Xiong X; Tang YP
J Neurosci Res; 2008 May; 86(7):1615-25. PubMed ID: 18189321
[TBL] [Abstract][Full Text] [Related]
29. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity.
Avital A; Goshen I; Kamsler A; Segal M; Iverfeldt K; Richter-Levin G; Yirmiya R
Hippocampus; 2003; 13(7):826-34. PubMed ID: 14620878
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
31. Colivelin Ameliorates Impairments in Cognitive Behaviors and Synaptic Plasticity in APP/PS1 Transgenic Mice.
Wu M; Shi H; He Y; Yuan L; Qu X; Zhang J; Wang Z; Cai H; Qi J
J Alzheimers Dis; 2017; 59(3):1067-1078. PubMed ID: 28731445
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease.
Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N
Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930
[TBL] [Abstract][Full Text] [Related]
33. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
34. Expression of familial Alzheimer's disease-linked human presenilin 1 variants impair enrichment-induced adult hippocampal neurogenesis.
Veeraraghavalu K; Choi SH; Sisodia SS
Neurodegener Dis; 2010; 7(1-3):46-9. PubMed ID: 20160458
[TBL] [Abstract][Full Text] [Related]
35. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models.
Stutzmann GE; Smith I; Caccamo A; Oddo S; Parker I; Laferla F
Ann N Y Acad Sci; 2007 Feb; 1097():265-77. PubMed ID: 17413028
[TBL] [Abstract][Full Text] [Related]
36. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.
Yamin G
J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166
[TBL] [Abstract][Full Text] [Related]
37. Functional phenotype in transgenic mice expressing mutant human presenilin-1.
Barrow PA; Empson RM; Gladwell SJ; Anderson CM; Killick R; Yu X; Jefferys JG; Duff K
Neurobiol Dis; 2000 Apr; 7(2):119-26. PubMed ID: 10783295
[TBL] [Abstract][Full Text] [Related]
38. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of calbindin D(28k) in dentate gyrus granule cells alters mossy fiber presynaptic function and impairs hippocampal-dependent memory.
Dumas TC; Powers EC; Tarapore PE; Sapolsky RM
Hippocampus; 2004; 14(6):701-9. PubMed ID: 15318329
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.
Sato N; Urano F; Yoon Leem J; Kim SH; Li M; Donoviel D; Bernstein A; Lee AS; Ron D; Veselits ML; Sisodia SS; Thinakaran G
Nat Cell Biol; 2000 Dec; 2(12):863-70. PubMed ID: 11146649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
